Breaking News Instant updates and real-time market news.

AAPL

Apple

$190.76

3.95 (2.11%)

15:44
11/15/18
11/15
15:44
11/15/18
15:44

Apple partners with A24 to make feature-length movies, Variety says

Apple is enlisting indie studio A24 to produce a slate of films for the tech giant, according to Variety. The partnership comes as Apple is delving more deeply into making its own shows and movies, having previously signed deals with the likes of Steven Spielberg, Reese Witherspoon, and Oprah Winfrey, the report added. Apple did not provide many specifics about the deal beyond saying it was a "multiyear agreement" and involved multiple movies, the publication noted. Reference Link

AAPL Apple
$190.76

3.95 (2.11%)

11/14/18
DADA
11/14/18
NO CHANGE
Target $72
DADA
Neutral
Qorvo price target lowered to $72 from $81 at DA Davidson
DA Davidson analyst Thomas Diffely lowered his price target on Qorvo (QRVO) to $72 and kept his Neutral rating after the company cut its Q3 earnings guidance to reflect the expectations of a weaker high-end smartphone demand. The analyst believes that the "softer than expected" launch of the new iPhones by Apple (AAPL) has " triggered a rapid change in order flow over the past couple of weeks" and anticipates similar announcements from other Apple suppliers to track reduced guidance by Qorvo and Lumentum (LITE).
11/14/18
LOOP
11/14/18
NO CHANGE
Target $85
LOOP
Buy
Qorvo price target lowered to $85 from $90 at Loop Capital
Loop Capital analyst Cody Acree lowered his price target on Qorvo (QRVO) to $85 after its reduced Q3 guidance, saying the "softer unit volumes" sold by Apple (AAPL) were "undoubtedly the primary unnamed specific cause". The analyst is keeping his Buy rating on the shares however, stating that the "tier-1 smartphone unit weakness is becoming a common theme" that is generating lesser impact with each news release as evidenced by Qorvo's shares trading flat yesterday. Acree adds that investors should start to "pick their spots for 2019" amid the smartphone industry's start of migration to 5G and believes that Qorvo is "well positioned to continue to gain share at the leading tier-1 handset OEMs".
11/14/18
11/14/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Apple (AAPL) downgraded to Neutral from Buy at Guggenheim with analyst Robert Cihra saying the average selling price of the iPhone has increased a "dramatic" $220, or 40%, over the past 10 years, reflecting its "growing value to both consumer and business markets." 2. Kellogg (K) downgraded to Neutral from Overweight at JPMorgan with analyst Ken Goldman saying that while nothing at the company's investor day "necessarily disappointed" him, he also did not gain "much comfort that the bottom-line turnaround would be swift." 3. Apollo Global (APO) and Carlyle Group (CG) were downgraded to Equal Weight from Overweight at Morgan Stanley. 4. Conagra Brands (CAG) downgraded to Underperform from Market Perform at Bernstein with analyst Alexia Howard saying the frozen category has experienced positive growth over the past year, largely led by new product innovation from Conagra and Pinnacle Foods, but this now seems to be running out of steam. 5. Tenneco (TEN) downgraded to Underweight from Equal Weight at Morgan Stanley with analyst Armintas Sinkevicius citing its elevated leverage and limited free cash flow conversion in what he views as an increasingly uncertain environment for auto suppliers. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/15/18
MSCO
11/15/18
NO CHANGE
Target $253
MSCO
Overweight
Apple dip a buying opportunity amid supply chain 'noise,' says Morgan Stanley
Morgan Stanley analyst Katy Huberty called the 8.5% decline in Apple (AAPL) shares following Lumentum's (LITE) and Qorvo's (QRVO) negative pre-announcements this week a buying opportunity, noting that she is still bullish on the iPhone maker's Services growth. Services will "take the growth baton" from Devices as the smartphone market matures, contends Huberty. While she believes investors should focus on Services rather than iPhone units, Huberty also believes Apple's December quarter guidance incorporates the revisions made by Lumentum and Qorvo, adding that unit revisions are typically more severe for the supply chain than Apple given inventory fluctuations and the company's steps to ensure adequate supply early in a product launch. Huberty keeps an Overweight rating and $253 price target on Apple shares.

TODAY'S FREE FLY STORIES

OKE

Oneok

$69.13

-0.59 (-0.85%)

06:30
04/22/19
04/22
06:30
04/22/19
06:30
Downgrade
Oneok rating change  »

Oneok downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 22

    May

CYAD

Celyad

$21.48

(0.00%)

06:29
04/22/19
04/22
06:29
04/22/19
06:29
Conference/Events
Celyad management to meet with »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 05

    Jun

JPM

JPMorgan

$113.43

-0.86 (-0.75%)

, BTC

Bitcoin

$0.00

(0.00%)

06:26
04/22/19
04/22
06:26
04/22/19
06:26
Periodicals
JPMorgan to expand use of blockchain system to validate payments, FT says »

JPMorgan Chase plans to…

JPM

JPMorgan

$113.43

-0.86 (-0.75%)

BTC

Bitcoin

$0.00

(0.00%)

BITCOIN

Bitcoin

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    May

  • 21

    May

  • 29

    May

  • 03

    Jun

  • 11

    Jun

  • 16

    Jul

OKE

Oneok

$69.13

-0.59 (-0.85%)

06:26
04/22/19
04/22
06:26
04/22/19
06:26
Downgrade
Oneok rating change  »

Oneok downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 22

    May

DTIL

Precision BioSciences

$12.15

-0.84 (-6.47%)

06:23
04/22/19
04/22
06:23
04/22/19
06:23
Initiation
Precision BioSciences initiated  »

Precision BioSciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APC

Anadarko

$64.18

0.16 (0.25%)

, CVX

Chevron

$119.87

-0.38 (-0.32%)

06:20
04/22/19
04/22
06:20
04/22/19
06:20
Downgrade
Anadarko, Chevron rating change  »

Anadarko downgraded to…

APC

Anadarko

$64.18

0.16 (0.25%)

CVX

Chevron

$119.87

-0.38 (-0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 30

    Apr

  • 14

    May

  • 22

    May

RTRX

Retrophin

$20.07

-0.13 (-0.64%)

06:18
04/22/19
04/22
06:18
04/22/19
06:18
Initiation
Retrophin initiated  »

Retrophin initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    May

  • 08

    May

  • 05

    Jun

  • 30

    Jun

MU

Micron

$43.42

0.26 (0.60%)

06:18
04/22/19
04/22
06:18
04/22/19
06:18
Conference/Events
Micron management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 24

    Apr

DTIL

Precision BioSciences

$12.15

-0.84 (-6.47%)

06:18
04/22/19
04/22
06:18
04/22/19
06:18
Initiation
Precision BioSciences initiated  »

Precision BioSciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WTRE

Watford Holdings

$28.24

0.5 (1.80%)

06:17
04/22/19
04/22
06:17
04/22/19
06:17
Initiation
Watford Holdings initiated  »

Watford Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RCII

Rent-A-Center

$21.35

0.07 (0.33%)

06:15
04/22/19
04/22
06:15
04/22/19
06:15
Upgrade
Rent-A-Center rating change  »

Rent-A-Center upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENGIY

Engie SA

$0.00

(0.00%)

, EME

Emcor

$79.55

2.64 (3.43%)

06:15
04/22/19
04/22
06:15
04/22/19
06:15
Periodicals
France's Engie mulls takeover of Emcor, Bloomberg reports »

French energy firm Engie…

ENGIY

Engie SA

$0.00

(0.00%)

EME

Emcor

$79.55

2.64 (3.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAL

Caleres

$27.55

0.425 (1.57%)

06:14
04/22/19
04/22
06:14
04/22/19
06:14
Upgrade
Caleres rating change  »

Caleres upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DOV

Dover

$97.93

1.12 (1.16%)

06:14
04/22/19
04/22
06:14
04/22/19
06:14
Downgrade
Dover rating change  »

Dover downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

TEVA

Teva

$14.36

0.14 (0.98%)

06:13
04/22/19
04/22
06:13
04/22/19
06:13
Hot Stocks
Teva receives FDA approval to market generic nasal spray for opioid overdoses »

The U.S. Food and Drug…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 03

    May

  • 04

    May

RCI

Rogers Communications

$51.39

-1.76 (-3.31%)

06:13
04/22/19
04/22
06:13
04/22/19
06:13
Downgrade
Rogers Communications rating change  »

Rogers Communications…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    May

  • 23

    May

TEVA

Teva

$14.36

0.14 (0.98%)

06:10
04/22/19
04/22
06:10
04/22/19
06:10
Hot Stocks
Teva receives FDA approval to market generic nasal spray for opioid overdoses »

The U.S. Food and Drug…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 03

    May

  • 04

    May

CAL

Caleres

$27.55

0.425 (1.57%)

06:09
04/22/19
04/22
06:09
04/22/19
06:09
Upgrade
Caleres rating change  »

Caleres upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TBK

Triumph Bancorp

$29.38

-1.37 (-4.46%)

06:08
04/22/19
04/22
06:08
04/22/19
06:08
Downgrade
Triumph Bancorp rating change  »

Triumph Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

  • 01

    May

  • 16

    May

OKE

Oneok

06:08
04/22/19
04/22
06:08
04/22/19
06:08
Downgrade
Oneok rating change  »

Oneok downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 22

    May

MANH

Manhattan Associates

$57.31

0.18 (0.32%)

06:07
04/22/19
04/22
06:07
04/22/19
06:07
Upgrade
Manhattan Associates rating change  »

Manhattan Associates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 14

    May

NSANY

Nissan

$0.00

(0.00%)

06:07
04/22/19
04/22
06:07
04/22/19
06:07
Hot Stocks
Nissan says Nikkei output cut report 'completely incorrect' »

Nissan said in a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALV

Autoliv

$86.75

1.26 (1.47%)

06:06
04/22/19
04/22
06:06
04/22/19
06:06
Downgrade
Autoliv rating change  »

Autoliv downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 06

    May

  • 07

    May

  • 07

    May

  • 08

    May

  • 23

    May

BXG

Bluegreen Vacations

$14.91

-0.43 (-2.80%)

06:06
04/22/19
04/22
06:06
04/22/19
06:06
Hot Stocks
Bass Pro to cancel access from Bluegreen Vacations »

As previously announced,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$273.25

2.13 (0.79%)

06:06
04/22/19
04/22
06:06
04/22/19
06:06
Periodicals
Tesla probes incident of vehicle fire in Shanghai, CNBC reports »

Tesla immediately sent a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Apr

  • 24

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.